Simcere Pharmaceutical Group Limited

HK$11.09As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2096Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR 2.69%
Div yield 1.89%
ROE 18.77%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.73
PE TTM 15.76
TSR TTM (8.37%)
Mkt cap HK$28.48B
ROIC 22.70%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
16.57%
(28.24%)
Hold 12|10|1|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.18
0.18
0.19
30.27%
40.17%
30.25%
20.94%
Revenue¥B
1.332
1.339
1.323
1.380
11.21%
6.72%
4.24%
3.64%
Peers (US$3.633B)
Cap (US$)
PE
3.738B
6.110x
Capital
TTM
5Y
10Y
Leveragex
0.730
0.255
0.254
EBIT/Intx
0.781
0.102
0.097
Own earn%
(86.67)
95.92
62.25
Sh yield%
12.94
11.24
14.14
Owners
Insiders/Inst%
7.10
57.98
Short interest%
5.82
SBC / revenue%
4.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
23–26
$1 testx
—
Incr. ROIC%
1